OSTEOARTROZ RIVOJLANISHIGA TASHKILIY VA ZAMONAVIY PATOGENETIK ASOSLARIGA NIGOH
##article.subject##:
osteoartroz, tibbiy yordam, tashkiliy va zamonaviy asoslar, patogenez##article.abstract##
Maqsad: osteoartroz (OA) kasalligida tibbiy yordam ko'rsatishni tashkiliy va zamonaviy asoslarini aniqlash va patogenetik rivojlanishni adabiyot taxlili.
Библиографические ссылки
Гаркави А.В. Остеоартроз. Медицинская газета. Профессиональное врачебное издание. 2012; 85:8-9
Коваленко В.Н., Борткевич О.П. Остеоартроз. Практическое руководство. К.: Морион; 2003
Матвеев Р.П., Брагина С.В. Остеоартроз коленного сустава: проблемы и социальная значимость // Экология человека. Медицинская экология. 2012.09, стр.53-62
Олюнин Ю.А. Диагностика и лечение остеоартроза в реальной клинической практике. ФГБУ НИИ ревматологии РАМН. М.: // Consilium Medicum. Неврология и ревматология. 2012;2:58-61.
Стасевич Н.Ю., Смыслов И.Н., Немсцверидзе Э.Я. Организационные основы совершенствования гериатрической помощи в медицинских учреждениях разной формы собственности / Социальные аспекты здоровья населения [сетевое издание] 2015; 42 (2). URL:http://vestnik.mednet.ru/content/view/671/30/lang,ru
Четина Е.В. Признаки дифференциации хондроцитов при формировании ранних повреждений хряща у пожилых людей // Научно-практическая ревматология. 2011. № 1. С. 33–39
Nüesch E., Dieppe P., Reichenbach S., Williams S., Iff S., Jüni P. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 2011; 342:d1165.
Hawker G.A., Croxford R., Bierman A.S., et al. All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study. PLoS One 2014; 9:e91286.
National Clinical Guideline Centre (UK). Osteoarthritis: Care and Management in Adults. London: National Institute for Health and Care Excellence (UK), 2014. https://www.ncbi.nlm.nih.gov/books/NBK248069/ (accessed Dec 8, 2020).
Kolasinski S.L., Neogi T., Hochberg M.C., et al. American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2020;72:149-62.
Bannuru R.R., Osani M.C., Vaysbrot E.E., et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019;27:1578-89.
Larochelle M.R., Zhang F., Ross-Degnan D., Wharam J.F. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010. Pharmacoepidemiol Drug Saf 2015; 24:885-92.
Krebs E.E., Gravely A., Nugent S., et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: The SPACE randomized clinical trial. // JAMA 2018; 319:872-82.
Busse J.W., Wang L., Kamaleldin M., et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. // JAMA.2018;.320:2448-60.
Busse J.W., Craigie S., Juurlink D.N., et al. Guideline for opioid therapy and chronic noncancer pain. // CMA J 2017; 189: E659-66.
Avouac J., Gossec L.,Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007; 15:957-65.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396:1204-22.
Jeffery M.M., Hooten W.M., Henk H.J., et al. Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study. BMJ 2018; 362:k2833.
Power J.D., Perruccio A.V., Gandhi R., et al. Factors associated with opioid use in presurgical knee, hip, and spine osteoarthritis patients. Arthritis Care Res (Hoboken) 2019; 71:1178-85.
Desai R.J., Jin Y., Franklin P.D., et al. Association of geography and access to health care providers with long-term prescription opioid use in Medicare patients with severe osteoarthritis: a cohort study. // Arthritis Rheumatol.2019; 71:712-21.
Cao Z., Zhou J., Long Z., et al. Targeting nerve growth factor, a new option for treatment of osteoarthritis: a network meta-analysis of comparative efficacy and safety with traditional drugs. Aging (Albany NY).2020; 13:1051-70.
Smith S.R., Deshpande B.R., Collins J.E., Katz J.N., Losina E. Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review. // Osteoarthritis Cartilage 2016; 24:962-72.
Zeng C., Wei J., Persson M.S.M., et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med 2018; 52:642-50.
da Costa B.R., Saadat P., Basciani R.M., et al. Visual Analogue Scale has higher assay sensitivity than WOMAC pain in detecting between-group differences in treatment effects: a meta-epidemiological study. Osteoarthritis Cartilage 2021; 29:304-12.
Dias S., Welton N.J., Sutton A.J., Ades A.E. NICE DSU Technical Support Document 2: A generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. National Institute for Health and Care Excellence (NICE), London. 2014. https://www.ncbi.nlm.nih.gov/books/NBK310366/.
Feng X., Tian M., Zhang W., Mei H. Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis. PLoS One 2018; 13:e0190798.
Persson M.S.M., Stocks J., Walsh D.A., Doherty M., Zhang W. The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: a network meta-analysis of randomised controlled trials. Osteoarthritis Cartilage 2018; 26:1575-82.
